pharmaceutical investing Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity
pharmaceutical investing Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
pharmaceutical investing Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials
Homerun Resources Inc. Announces Approval by ANM of Final Exploration Report for Mineral Rights Leased from CBPM in the Santa Maria Eterna High Purity Silica District
FPX Nickel Joins Mining Association of Canada and Signs on to UN Global Compact, Demonstrating Industry Leadership in Sustainable and Responsible Project Development
